drugset / Trial / NCT02972411

Controlled Hyperventilation as Prophylaxis for Acute Mountain Sickness

NCT02972411

RandomizedParallel-groupSingle-blindPrevention

Summary

This study evaluates the safety and efficacy of the voluntary ventilatory response as prophylaxis for acute mountain sickness, measured by the Lake Louise Self-Report Score, comparing to a group using acetazolamide.

Timeline

Start
2016-10
Primary completion
2017-05
Completion
2017-05

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Acetazolamide Small molecule 125 mg Oral

Indications